The efficacy of gallium scintigraphy in detecting malignant soft tissue neoplasms.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 1731652.
- Also identified by PMC identifier 1242373.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A prospective study was conducted on 55 consecutive patients to evaluate the efficacy of gallium scintigraphy in detecting malignancy in any soft tissue mass. It was determined that gallium scintigraphy could detect malignancy with a sensitivity of 96% and a specificity of 87%. Large and small sarcomas, irrespective of their fascial location, were identifiable by gallium imaging. Occult, nonpulmonary sites of disseminated disease were detected in 13%. Gallium scintigraphy proved to be a reliable predictor of malignancy for all soft tissue masses, but because of its cost, it must be used judiciously.
Medical subject headings
- Gallium Radioisotopes
- Soft Tissue Neoplasms